Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study
Background. Acute postoperative pain delays recovery and increases morbidity and mortality. Traditional administration of postoperative analgesics by nurses is often inefficient. The present study evaluated the safety, efficacy, and usability of a novel, patient-controlled analgesic dispenser, the P...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2017/7962135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849397035642388480 |
|---|---|
| author | Stefan Wirz Stefan Conrad Ronit Shtrichman Kai Schimo Eva Hoffmann |
| author_facet | Stefan Wirz Stefan Conrad Ronit Shtrichman Kai Schimo Eva Hoffmann |
| author_sort | Stefan Wirz |
| collection | DOAJ |
| description | Background. Acute postoperative pain delays recovery and increases morbidity and mortality. Traditional administration of postoperative analgesics by nurses is often inefficient. The present study evaluated the safety, efficacy, and usability of a novel, patient-controlled analgesic dispenser, the PCoA Acute. Methods. A controlled pilot study was conducted at three medical centers. Patients scheduled for elective surgery were enrolled into two groups, both taking oral analgesics: a control group (n=43), opioids dispensed by nurses, and a test group (n=27), opioids dispensed via the PCoA Acute. Pill intake data were recorded. Pain ratings at rest and during movement were surveyed. Results. No severe adverse events were recorded. Average pill intake time was reduced from 8 : 58 minutes in the control group to 1 : 17 minutes in the test group (P value < 0.05). The test group took 67% more pills than the control group, indicating enhanced compliance. Pain scores were significantly lower for patients in the test group (P value < 0.05). Over 90% of PCoA Acute users were satisfied with its use. Conclusions. The study confirmed that PCoA Acute is safe and effective. It is well accepted by patients and medical staff. Its use can optimize pain medication administration. |
| format | Article |
| id | doaj-art-a9bd9ddd8b0a497f85e74fbe3a39f0c6 |
| institution | Kabale University |
| issn | 1203-6765 1918-1523 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-a9bd9ddd8b0a497f85e74fbe3a39f0c62025-08-20T03:39:10ZengWileyPain Research and Management1203-67651918-15232017-01-01201710.1155/2017/79621357962135Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility StudyStefan Wirz0Stefan Conrad1Ronit Shtrichman2Kai Schimo3Eva Hoffmann4Department of Anesthesia, Intensive Medicine, Pain Medicine/Palliative Medicine, Center for Pain Medicine, CURA Hospital GFO, Bad Honnef, GermanyDosentRx Ltd., 2 Hahar St., Har Tuv Industrial Zone A, 9980101 Har Tuv, IsraelDosentRx Ltd., 2 Hahar St., Har Tuv Industrial Zone A, 9980101 Har Tuv, IsraelDosentRx Ltd., 2 Hahar St., Har Tuv Industrial Zone A, 9980101 Har Tuv, IsraelDepartment of Anesthesia, Interdisciplinary Intensive Care, Emergency Medicine and Pain Medicine, EvK-Protestant Hospital Herne, Herne, GermanyBackground. Acute postoperative pain delays recovery and increases morbidity and mortality. Traditional administration of postoperative analgesics by nurses is often inefficient. The present study evaluated the safety, efficacy, and usability of a novel, patient-controlled analgesic dispenser, the PCoA Acute. Methods. A controlled pilot study was conducted at three medical centers. Patients scheduled for elective surgery were enrolled into two groups, both taking oral analgesics: a control group (n=43), opioids dispensed by nurses, and a test group (n=27), opioids dispensed via the PCoA Acute. Pill intake data were recorded. Pain ratings at rest and during movement were surveyed. Results. No severe adverse events were recorded. Average pill intake time was reduced from 8 : 58 minutes in the control group to 1 : 17 minutes in the test group (P value < 0.05). The test group took 67% more pills than the control group, indicating enhanced compliance. Pain scores were significantly lower for patients in the test group (P value < 0.05). Over 90% of PCoA Acute users were satisfied with its use. Conclusions. The study confirmed that PCoA Acute is safe and effective. It is well accepted by patients and medical staff. Its use can optimize pain medication administration.http://dx.doi.org/10.1155/2017/7962135 |
| spellingShingle | Stefan Wirz Stefan Conrad Ronit Shtrichman Kai Schimo Eva Hoffmann Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study Pain Research and Management |
| title | Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study |
| title_full | Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study |
| title_fullStr | Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study |
| title_full_unstemmed | Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study |
| title_short | Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study |
| title_sort | clinical evaluation of a novel technology for oral patient controlled analgesia the pcoa r acute device for hospitalized patients with postoperative pain in pilot feasibility study |
| url | http://dx.doi.org/10.1155/2017/7962135 |
| work_keys_str_mv | AT stefanwirz clinicalevaluationofanoveltechnologyfororalpatientcontrolledanalgesiathepcoaacutedeviceforhospitalizedpatientswithpostoperativepaininpilotfeasibilitystudy AT stefanconrad clinicalevaluationofanoveltechnologyfororalpatientcontrolledanalgesiathepcoaacutedeviceforhospitalizedpatientswithpostoperativepaininpilotfeasibilitystudy AT ronitshtrichman clinicalevaluationofanoveltechnologyfororalpatientcontrolledanalgesiathepcoaacutedeviceforhospitalizedpatientswithpostoperativepaininpilotfeasibilitystudy AT kaischimo clinicalevaluationofanoveltechnologyfororalpatientcontrolledanalgesiathepcoaacutedeviceforhospitalizedpatientswithpostoperativepaininpilotfeasibilitystudy AT evahoffmann clinicalevaluationofanoveltechnologyfororalpatientcontrolledanalgesiathepcoaacutedeviceforhospitalizedpatientswithpostoperativepaininpilotfeasibilitystudy |